COVID-19 Kitasato Project; Investigator-initiated clinical trial of ivermectin for additional indication to COVID-19

  • Funded by Japan Agency for Medical Research and Development (AMED)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2020
  • Funder

    Japan Agency for Medical Research and Development (AMED)
  • Principal Investigator

    Professor Kunihiro YAMAOKA
  • Research Location

    Japan
  • Lead Research Institution

    Department of Rheumatology and Infectious Diseases, Kitasato University
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract